COO - The Cooper Companies, Inc.
After hours:
| Previous close | 349.79 |
| Open | 349.71 |
| Bid | 345.52 x 800 |
| Ask | 351.01 x 800 |
| Day's range | 344.38 - 349.72 |
| 52-week range | 244.22 - 395.20 |
| Volume | |
| Avg. volume | 298,841 |
| Market cap | 17.137B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 59.58 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.06 (0.02%) |
| Ex-dividend date | 20 Jan 2023 |
| 1y target est | N/A |
- Zacks
XRAY or COO: Which Is the Better Value Stock Right Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
- Zacks
Down -7.64% in 4 Weeks, Here's Why The Cooper Companies (COO) Looks Ripe for a Turnaround
The Cooper Companies (COO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Simply Wall St.
What Is The Cooper Companies, Inc.'s (NYSE:COO) Share Price Doing?
Let's talk about the popular The Cooper Companies, Inc. ( NYSE:COO ). The company's shares saw a decent share price...
- Zacks
Cooper Companies (COO) Q2 Earnings and Revenues Beat Estimates
Cooper Companies' (COO) second-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.
- Zacks
The Cooper Companies (COO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- Zacks
The Cooper Companies (COO) Q2 Earnings and Revenues Surpass Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of 2.33% and 1.75%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Is a Beat Likely for Cooper Companies (COO) in Q2 Earnings?
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
- Zacks
What Makes The Cooper Companies (COO) a New Buy Stock
The Cooper Companies (COO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and The Cooper Companies (COO) have performed compared to their sector so far this year.
- Zacks
XRAY vs. COO: Which Stock Is the Better Value Option?
XRAY vs. COO: Which Stock Is the Better Value Option?
- Zacks
Why You Should Buy The Cooper Companies (COO) Stock Now
The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.
- Zacks
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Misses Revenue Estimates
AnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of -51.92% and 65.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Henry Schein (HSIC) Q1 Earnings and Revenues Miss Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of -2.42% and 1.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
- Zacks
Cardinal Health (CAH) Tops Q3 Earnings and Revenue Estimates
Cardinal (CAH) delivered earnings and revenue surprises of 17.57% and 1.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Zacks Industry Outlook Highlights West Pharmaceutical Services, The Cooper Companies and Henry Schein
West Pharmaceutical Services, The Cooper Companies and Henry Schein have been highlighted in this Industry Outlook article.
- Zacks
3 Dental Supplies Stocks to Buy as Industry Prospects Recover
Here, we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, COO and HSIC.
- Zacks
Catalent (CTLT) Declines on Profit Warnings and CFO Exit
Catalent (CTLT) issues a profit warning for third-quarter fiscal 2023 amid supply chain disruptions and operational challenges. It also announces the departure of its CFO.
- Simply Wall St.
Cooper Companies (NYSE:COO) Might Be Having Difficulty Using Its Capital Effectively
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
- Zacks
Here's Why You Should Retain Surmodics (SRDX) Stock for Now
Investors continue to feel optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.
- Zacks
Reasons to Add The Cooper Companies (COO) to Your Portfolio
The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.
- Simply Wall St.
Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cooper Companies fair value estimate is US$329 Current share...
- Zacks
Here's Why You Should Retain Patterson Companies (PDCO) Stock
Investors are optimistic about Patterson Companies' (PDCO) strong product line.
- Zacks
Is Clene (CLNN) Stock Outpacing Its Medical Peers This Year?
Here is how Clene Inc. (CLNN) and The Cooper Companies (COO) have performed compared to their sector so far this year.
- Zacks
PacBio's (PACB) Latest Offering to Enhance Genome Analysis
PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.
